Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Rectal Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Lipodystrophy, Familial Partial 1Hematologic Neoplasms 1Hematologic Diseases 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

pomalidomide 1daratumumab 1Quality of Life 1Observation 1Genetic Testing 1Electrocardiography 1Dexamethasone 1Complementary Therapies 1Clinical Laboratory Techniques 1Bone Marrow Examination 1Azacitidine 111-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Hematologic Diseases × Genetic Testing × Clear all
NCT06843291 2025-02-24

UNIVERSAL GENETIC TESTING OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (UGT)

Augusta University

Phase NA Not yet recruiting
100 enrolled
Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡